Breakout Ventures
@breakout-ventures.bsky.social
Investing in early-stage companies that are building the future with science. Learn more at breakout.vc
It's not every day that your portfolio company's CEO 𝒂𝒏𝒅 your firm's Managing Partner land a spot on @cnbc.com 🎉 Congrats to Harshal and the ZymoChem team, and thanks for inviting our very own Lindy to join you on screen!
June 27, 2025 at 3:54 PM
It's not every day that your portfolio company's CEO 𝒂𝒏𝒅 your firm's Managing Partner land a spot on @cnbc.com 🎉 Congrats to Harshal and the ZymoChem team, and thanks for inviting our very own Lindy to join you on screen!
With the launch of their OCTO-VirtualCell (OCTO-vc) and Celleporter visualization tool, NOETIK is taking the world a (𝒃𝒊𝒈) step forward in how we understand and interact with biological systems.
December 18, 2024 at 3:55 PM
With the launch of their OCTO-VirtualCell (OCTO-vc) and Celleporter visualization tool, NOETIK is taking the world a (𝒃𝒊𝒈) step forward in how we understand and interact with biological systems.
Visionary entrepreneurs don't accept the status quo. The 10 years and $1B+ it takes to bring medicines from discovery to approval is unacceptable... and ready for a tech overhaul.
Thanks to everyone who joined our Magnify Debate to decide: how will computation reshape the drug development funnel?
Thanks to everyone who joined our Magnify Debate to decide: how will computation reshape the drug development funnel?
November 22, 2024 at 8:51 PM
Visionary entrepreneurs don't accept the status quo. The 10 years and $1B+ it takes to bring medicines from discovery to approval is unacceptable... and ready for a tech overhaul.
Thanks to everyone who joined our Magnify Debate to decide: how will computation reshape the drug development funnel?
Thanks to everyone who joined our Magnify Debate to decide: how will computation reshape the drug development funnel?